1. Department of Molecular Medicine, University of Pavia, Pavia, Italy;
2. Laboratory of Biochemistry, Biotechnology and Advanced Diagnosis, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo Foundation, Pavia, Italy;
3. Unité Mixte de Recherche (UMR) 1170, Gustave Roussy, Université Paris-Sud, INSERM, Villejuif, France;
4. Laboratory of General Physiology, Department of Biology and Biotechnology “Lazzaro Spallanzani,” University of Pavia, Pavia, Italy;
5. Department of Hematology Oncology, Foundation IRCCS Policlinico San Matteo, Pavia, Italy;
6. Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Novara, Italy;
7. Hematology Division, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy;
8. Center for the Study of Myelofibrosis, Foundation IRCCS Policlinico San Matteo, Pavia, Italy; and
9. Department of Biomedical Engineering, Tufts University, Medford, MA